jpo at siris7 (John Overington) wrote:
> We (Peter Murray-Rust of Glaxo Wellcome, and John Overington of Pfizer)
>would like to announce an initiative in industrial training for medicinal
>chemists interested in applying protein structure-based drug design (SBDD)
>techniques as part of their jobs. Additionally, skills in effectively using
>the internet as a scientific resource will also be developed. The course will
>use self-paced, internet-based training, coupled to close contact with
>course 'tutors', working in the pharmaceutical industry.
>> We are currently looking for further partners to offer financial support,
>and course material. Partners need to have a presence in the UK to qualify for
>potential funding under a Technology Foresight grant; although the basic
>course material will be generally accessible over the internet to the wider
>community.
>> Further details, and a draft prospectus can be found at
>http://www.cryst.bbk.ac.uk/SBDD/course.html>> If you have any further questions, we would be pleased to answer them.
>> John Overington jpo at guitar.rockefeller.edu> Peter Murray-Rust ubcg09q at cryst.bbk.ac.uk>>--
>Dr. John Overington email: overingtonj at pfizer.com>Pfizer Central Research phone: +44-(0)1304-618467
>Sandwich, Kent, CT13 9NJ fax: +44-(0)1304-618422
>United Kingdom cc-mail: overington_j at sandwich.pfizer.com
